Sugi Predict

Sugi Predict / Compounds / SCHEMBL9966293

SCHEMBL9966293

SCHEMBL9966293

Nc1ncc(-c2ccc(C3(C(=O)Nc4ccc(N5CCOCC5)c(Cl)c4)CCC3)cc2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 8/20 0.56
▸ NPY2R P49146 1/20 0.51
▸ ALDH1A1 P00352 7/20 0.47
▸ HPGD P15428 4/20 0.47
▸ TSHR P16473 2/20 0.47
▸ SMN1; SMN2 Q16637 6/20 0.46
▸ HTT P42858 6/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ MAPT P10636 8/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ DGAT1 O75907 1/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9966398 0.95 LMNA (0.49) LMNANPY2RALDH1A1HPGDTSHR
SCHEMBL14314003 0.88 LMNA (0.44) LMNAALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL9966288 0.87 LMNA (0.67) LMNAALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL9966203 0.84 HDAC1 (0.55) LMNAL3MBTL1TP53MAPTRAB9A
SCHEMBL9966546 0.84 IDO1 (0.46) LMNANPY2RALDH1A1CYP2C9
SCHEMBL14315771 0.83 MAP4K4 (0.50) LMNATSHRL3MBTL1TP53MAPT
SCHEMBL9966228 0.82 LMNA (0.60) LMNAALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL9966426 0.81 LMNA (0.49) LMNAALDH1A1SMN1; SMN2HTTMEN1
SCHEMBL9966488 0.80 MAP4K4 (0.44) NPY2RALDH1A1CYP2C9
SCHEMBL9966481 0.80 MAP4K4 (0.48) LMNAL3MBTL1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651930-B1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INT (DE) 2015-10-28 — — EP disclosed
US-9073895-B2 Biarylamide inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 — — US disclosed
US-9073895-B2 Biarylamide inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 — — US disclosed
US-9073895-B2 Biarylamide inhibitors of leukotriene production BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 — — US disclosed
WO-2012082817-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322795-A1 BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION LTB4R, LTB4R2, LTC4S LMNA 351/4885NPY2R 967/4885ALDH1A1 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.